Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.76)
# 3,823
Out of 4,859 analysts
307
Total ratings
22.02%
Success rate
-30.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Reiterates: Buy | $12 | $0.93 | +1,192.13% | 23 | Jun 11, 2025 | |
| ARTV Artiva Biotherapeutics | Assumes: Buy | $12 | $2.09 | +474.16% | 1 | Jun 11, 2025 | |
| AGEN Agenus | Upgrades: Buy | $25 | $4.93 | +407.10% | 18 | Jun 4, 2025 | |
| ANAB AnaptysBio | Upgrades: Buy | $22 → $38 | $23.60 | +61.02% | 9 | Jun 4, 2025 | |
| RAPT RAPT Therapeutics | Assumes: Buy | $6 | $1.10 | +445.45% | 1 | May 22, 2025 | |
| SABS SAB Biotherapeutics | Assumes: Buy | $10 | $1.73 | +478.03% | 1 | May 14, 2025 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | $30 | $4.13 | +627.27% | 20 | Apr 28, 2025 | |
| SANA Sana Biotechnology | Reiterates: Buy | $11 | $2.50 | +340.88% | 11 | Apr 24, 2025 | |
| BCTX BriaCell Therapeutics | Reiterates: Buy | $32 | $3.56 | +798.88% | 14 | Apr 22, 2025 | |
| RNAZ TransCode Therapeutics | Maintains: Buy | $560 → $280 | $7.37 | +3,699.19% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $16.25 | +121.54% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.88 | +809.09% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.50 | +700.00% | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.55 | +1,076.47% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.30 | +1,361.54% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.94 | +830.23% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.63 | +761.54% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.87 | +707.80% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.63 | +697.32% | 11 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $7.30 | +379.42% | 12 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.66 | +356.83% | 8 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.55 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.53 | +623.33% | 9 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $9.44 | +154.24% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $34.95 | +65.95% | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.61 | +2,848.40% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.50 | - | 15 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $18.24 | +108.33% | 18 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $66.92 | +71.85% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $2.46 | +1,241.46% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.35 | - | 1 | Apr 25, 2024 |
Femasys
Jun 11, 2025
Reiterates: Buy
Price Target: $12
Current: $0.93
Upside: +1,192.13%
Artiva Biotherapeutics
Jun 11, 2025
Assumes: Buy
Price Target: $12
Current: $2.09
Upside: +474.16%
Agenus
Jun 4, 2025
Upgrades: Buy
Price Target: $25
Current: $4.93
Upside: +407.10%
AnaptysBio
Jun 4, 2025
Upgrades: Buy
Price Target: $22 → $38
Current: $23.60
Upside: +61.02%
RAPT Therapeutics
May 22, 2025
Assumes: Buy
Price Target: $6
Current: $1.10
Upside: +445.45%
SAB Biotherapeutics
May 14, 2025
Assumes: Buy
Price Target: $10
Current: $1.73
Upside: +478.03%
Olema Pharmaceuticals
Apr 28, 2025
Reiterates: Buy
Price Target: $30
Current: $4.13
Upside: +627.27%
Sana Biotechnology
Apr 24, 2025
Reiterates: Buy
Price Target: $11
Current: $2.50
Upside: +340.88%
BriaCell Therapeutics
Apr 22, 2025
Reiterates: Buy
Price Target: $32
Current: $3.56
Upside: +798.88%
TransCode Therapeutics
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $7.37
Upside: +3,699.19%
Apr 9, 2025
Initiates: Buy
Price Target: $36
Current: $16.25
Upside: +121.54%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $0.88
Upside: +809.09%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $1.50
Upside: +700.00%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $2.55
Upside: +1,076.47%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.30
Upside: +1,361.54%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.94
Upside: +830.23%
Mar 26, 2025
Reiterates: Buy
Price Target: $14
Current: $1.63
Upside: +761.54%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.87
Upside: +707.80%
Mar 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.63
Upside: +697.32%
Mar 18, 2025
Reiterates: Buy
Price Target: $35
Current: $7.30
Upside: +379.42%
Mar 17, 2025
Reiterates: Buy
Price Target: $3
Current: $0.66
Upside: +356.83%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.55
Upside: -
Mar 11, 2025
Reiterates: Buy
Price Target: $40
Current: $5.53
Upside: +623.33%
Feb 26, 2025
Upgrades: Buy
Price Target: $24
Current: $9.44
Upside: +154.24%
Feb 24, 2025
Reiterates: Buy
Price Target: $58
Current: $34.95
Upside: +65.95%
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.61
Upside: +2,848.40%
Jan 14, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.50
Upside: -
Jan 14, 2025
Reiterates: Buy
Price Target: $38
Current: $18.24
Upside: +108.33%
Dec 10, 2024
Reiterates: Buy
Price Target: $115
Current: $66.92
Upside: +71.85%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $2.46
Upside: +1,241.46%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.35
Upside: -